Quotes with Resistance & Support
Market Information

Sun Pharma gets approval to mkt generic Demadex tablets

This article was posted on Feb 28, 2008

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted final approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Hoffman la Roche’s Demadex®, torsemide tablets.These generic torsemide tablets are therapeutic equivalents of Hoffman la Roche’s Demadex® Tablets and include four strengths: 5 mg, 10 mg, 20 mg and 100 mg. These strengths of torsemide tablets have annual sales of approximately USD 35 million in the US.

Torsemide is a diuretic, indicated for the treatment of edema associated with congestive heart failure, renal disease, or hepatic disease. Use of torsemide has been found to be effective for the treatment of edema associated with chronic renal failure. Torsemide is also indicated for the treatment of hypertension alone or in combination with other antihypertensive agents.

The Company expects to reach the market shortly with these products.

Sourced From: Sun Pharmaceutical Industries Ltd

0 Responses

{ ADD YOUR OWN }

    1. Your name>
      Change your image

      Note: rel="nofollow" in use - do not spam, do not advertise!

    Interesting Posts:

    Breakouts

    +ve 30 DMA    50 DMA    150 DMA    200 DMA
    -ve 30 DMA    50 DMA    150 DMA    200 DMA

    Latest Query

    Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
    - by Sam
    Status: Awaiting reply

    Market Stats

    Search Our Archives

    Latest Investment Idea

    Recent Comments